4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-19-054773
Director sold 21,000 shares at $51.89 ($1,089,675)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bolzon Bradley J PhD Director | 2019-10-30 | Sale | −21,000 | $51.89 | $1,089,675 | 13,745 | D |
| Open-market sales · 21,000 sh · avg $51.89 · $1,089,675 | |||||||
Loading xslF345X03/doc4.xml…